Siegfried Holding
Siegfried Holding AG, commonly referred to as Siegfried, is a prominent player in the pharmaceutical and chemical industry, headquartered in Switzerland (CH). Founded in 1873, the company has established a strong presence in Europe and North America, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. Siegfried is renowned for its innovative solutions in contract development and manufacturing, catering to a diverse clientele in the pharmaceutical sector. The company’s commitment to quality and sustainability sets it apart, ensuring compliance with stringent regulatory standards. With a robust market position, Siegfried has achieved significant milestones, including strategic acquisitions that have expanded its capabilities and global reach. As a trusted partner in the pharmaceutical supply chain, Siegfried continues to drive advancements in drug development and production.
DitchCarbon Score
How does Siegfried Holding's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Siegfried Holding's score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Siegfried Holding's reported carbon emissions
In 2024, Siegfried Holding AG reported total carbon emissions of approximately 59171000 kg CO2e for Scope 1, 12622000 kg CO2e for Scope 2, and 459700000 kg CO2e for Scope 3, resulting in a combined total of about 71793000 kg CO2e for Scope 1 and 2 emissions. This reflects a slight increase in Scope 1 emissions from 58411000 kg CO2e in 2023, while Scope 2 emissions decreased from 14617000 kg CO2e in the previous year. Siegfried has set ambitious climate commitments, aiming for a 50% reduction in its Scope 1 and 2 emissions by 2030, based on 2020 revenue-adjusted figures. This target is part of a broader strategy to achieve net-zero greenhouse gas emissions across its value chain by 2050. Additionally, the company has committed to reducing its absolute Scope 1 and 2 emissions by 66.89% by 2033 from a 2020 baseline, and to cut Scope 3 emissions by 32.5% by 2033 from a 2022 baseline. These targets are aligned with the Science Based Targets initiative (SBTi) and reflect Siegfried's commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company is also focused on ensuring that 85% of its suppliers by emissions have science-based targets by 2029, further enhancing its sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 16,300,000 | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Siegfried Holding is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
